HC ANDERSEN CAPITAL

Ascelia Pharma – Presentation of H1 2025 Results

AUTHOR

Mie

DATE

8. July 2025

Ascelia Pharma – Presentation of H1 2025 Results

Ascelia Pharma - Presentation of H1 2025 Results 22 AugustAug 2025 10:00 - 10:30Online Event

Tilmeld

Information

Ascelia Pharma - Presentation of H1 2025 Results 22 AugustAug 2025 10:00 - 10:30

Ascelia Pharma - Presentation of H1 2025 Results Online Event

Tilmeld

GreenMobility – Guidance Upgrade and Preliminary Results

Wirtek – Presentation of Q2 2025 Interim Report

Explore our services

INFORMATION

Bredgade 23B 2. sal
1260 København K
View on map
Phone: 28 74 66 40
CVR: 41474793

About

What we do

HC Andersen Capital was established in 2020 and is at the forefront of digital Investor Relations, amplifying market presence.

Our tailored services encompass IR and ESG advisory, Legal Support, cutting-edge digital solutions such as IR websites and IR distribution software, Commissioned Research, Corporate Finance advisory and more. We are proudly Certified Adviser on Nasdaq First North Copenhagen.

About us

What we do in short

Advisory

IR Services

Our Community

Ascelia Pharma – Presentation of H1 2025 Results

Ascelia Pharma – Presentation of H1 2025 Results

Information

Explore our services

INFORMATION

About

What we do

2024 - HC Andersen Capital